5:48 PM
Jun 20, 2013
 |  BC Extra  |  Financial News

Progenics raises $37.4 million in follow-on

Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) raised $37.4 million through the sale of 8.5 million shares at $4.40 in a follow-on underwritten by Jefferies; Needham; Stifel; and Brean Capital. Progenics proposed the offering...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >